Polaryx Therapeutics, Inc. (PLYX)
NASDAQ: PLYX · Real-Time Price · USD
5.63
+0.56 (11.05%)
At close: Apr 28, 2026, 4:00 PM EDT
5.61
-0.02 (-0.36%)
Pre-market: Apr 29, 2026, 4:08 AM EDT
Polaryx Therapeutics Market Cap
Polaryx Therapeutics has a market cap or net worth of $266.54 million as of April 28, 2026.
Market Cap
266.54M
Enterprise Value
261.40M
1-Year Change
n/a
Ranking
Category
Stock Price
$5.63
Market Cap Chart
Since February 2, 2026, Polaryx Therapeutics's market cap has decreased from $1.66B to $266.54M, a decrease of -83.91%. That is a compound annual growth rate of -99.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 240.03M | -85.51% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sol-Gel Technologies | 251.71M |
| SAB Biotherapeutics | 244.21M |
| Codexis | 240.80M |
| Orchestra BioMed Holdings | 239.94M |
| Arcturus Therapeutics Holdings | 235.91M |
| Fennec Pharmaceuticals | 235.47M |
| Adagene | 235.22M |
| Nuvectis Pharma | 231.80M |